Overview

Diapulse^® Corporation of America is the pioneer and leader in the biophysical therapeutic effects of non-thermal pulsed electromagnetic energy in medicine. The Company manufacturers, researches and develops the proprietary Diapulse^® medical technology. It is indicated for the adjunctive use in the palliative treatment of postoperative edema and pain in superficial soft tissues in acute and chronic wounds.

Diapulse^® is Medicare Covered to treat stage 2, 3, and 4 pressure ulcers, venous stasis ulcers, arterial ulcers, and diabetic ulcers in Hospitals, Nursing Homes, Therapy Clinics and Physician Offices.

[Home] [About Us] [References] [Quote] [Contact Us]